{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:12:39Z","timestamp":1758672759791,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01006-0","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T01:37:24Z","timestamp":1749433044000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype-dependent heterogeneity of THSD7A expression in gastric cancer tissue in a patient with THSD7A-associated membranous nephropathy"],"prefix":"10.1007","volume":"14","author":[{"given":"Chisato","family":"Minezaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-5788","authenticated-orcid":false,"given":"Tatsuhiko","family":"Azegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashin","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aika","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"1006_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1368457","author":"X Hu","year":"2024","unstructured":"Hu X, Wang G, Cheng H. Specific antigens in malignancy-associated membranous nephropathy. Front Med (Lausanne). 2024. https:\/\/doi.org\/10.3389\/fmed.2024.1368457.","journal-title":"Front Med (Lausanne)"},{"key":"1006_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276053","author":"J Storrar","year":"2022","unstructured":"Storrar J, Gill-Taylor T, Chinnadurai R, Chrysochou C, Poulikakos D, Rainone F, et al. A low rate of end-stage kidney disease in membranous nephropathy: a single centre study over 2 decades. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0276053.","journal-title":"PLoS ONE"},{"key":"1006_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02348-4","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Cai M, Dong B, Yan Y, Wang Y, Li X, et al. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study. BMC Nephrol. 2021. https:\/\/doi.org\/10.1186\/s12882-021-02348-4.","journal-title":"BMC Nephrol"},{"key":"1006_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00564-1","author":"E Hoxha","year":"2022","unstructured":"Hoxha E, Reinhard L, Stahl R. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022. https:\/\/doi.org\/10.1038\/s41581-022-00564-1.","journal-title":"Nat Rev Nephrol"},{"key":"1006_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2023.08.006","author":"S Sethi","year":"2023","unstructured":"Sethi S, Glassock RJ, Haas M, Vriese ASD, Caza TN, Hoxha E, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Mayo Clin Proc. 2023. https:\/\/doi.org\/10.1016\/j.mayocp.2023.08.006.","journal-title":"Mayo Clin Proc"},{"key":"1006_CR6","doi-asserted-by":"publisher","DOI":"10.1159\/000364782","author":"N Leeaphorn","year":"2014","unstructured":"Leeaphorn N, Kue APP, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014. https:\/\/doi.org\/10.1159\/000364782.","journal-title":"Am J Nephrol"},{"key":"1006_CR7","first-page":"559","volume-title":"Pathology of the kidney","author":"MM Schwartz","year":"1992","unstructured":"Schwartz MM. Membranous glomerulonephritis. In: Little RH, editor. Pathology of the kidney. 4th ed. Boston: Little Brown and Company; 1992. p. 559\u2013626.","edition":"4"},{"key":"1006_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.32","author":"H Imai","year":"1997","unstructured":"Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997. https:\/\/doi.org\/10.1038\/ki.1997.32.","journal-title":"Kidney Int"},{"key":"1006_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1983.170","author":"JC Jennette","year":"1983","unstructured":"Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983. https:\/\/doi.org\/10.1038\/ki.1983.170.","journal-title":"Kidney Int"},{"key":"1006_CR10","volume-title":"WHO classification of tumours: digestive system tumours","author":"WHO","year":"2019","unstructured":"WHO. Classification of Tumours Editorial Board. In: WHO classification of tumours: digestive system tumours. 5th ed. Lyon: IARC; 2019.","edition":"5"},{"key":"1006_CR11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-64-1-41","author":"CJ Lee","year":"1966","unstructured":"Lee CJ, Yamauchi H, Hopper J. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966. https:\/\/doi.org\/10.7326\/0003-4819-64-1-41.","journal-title":"Ann Intern Med"},{"key":"1006_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad225","author":"Y Radhakrishnan","year":"2024","unstructured":"Radhakrishnan Y, Zand L, Sethi S, Fervenza FC. Membranous nephropathy treatment standard. Nephrol Dial Transplant. 2024. https:\/\/doi.org\/10.1093\/ndt\/gfad225.","journal-title":"Nephrol Dial Transplant"},{"key":"1006_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029000","author":"MW Kuo","year":"2011","unstructured":"Kuo MW, Wang CH, Wu HC, Chang SJ, Chuang YJ. Soluble THSD7A Is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis. PLoS ONE. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0029000.","journal-title":"PLoS ONE"},{"key":"1006_CR14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409354","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014. https:\/\/doi.org\/10.1056\/NEJMoa1409354.","journal-title":"N Engl J Med"},{"key":"1006_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001790","author":"C Lefaucheur","year":"2006","unstructured":"Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006. https:\/\/doi.org\/10.1038\/sj.ki.5001790.","journal-title":"Kidney Int"},{"key":"1006_CR16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1511702","author":"E Hoxha","year":"2016","unstructured":"Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al. A mechanism for cancer-associated membranous nephropathy. N Engl J Med. 2016. https:\/\/doi.org\/10.1056\/NEJMc1511702.","journal-title":"N Engl J Med."},{"key":"1006_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1002155","author":"QQ Xu","year":"2022","unstructured":"Xu QQ, Zou GM, Zhuo L, Gao HM, Li WG. Lung cancer patients with nephropathy as the first manifestation: literature review and clinical study report. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.1002155.","journal-title":"Front Oncol"},{"key":"1006_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03035","author":"F Haxthausen","year":"2018","unstructured":"Haxthausen F, Reinhard L, Pinnschmidt HO, Rink M, Soave A, Hoxha E, et al. Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.03035.","journal-title":"Front Immunol"},{"key":"1006_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1236-y","author":"S Taguchi","year":"2019","unstructured":"Taguchi S, Koshikawa Y, Ohyama S, Miyachi H, Ozawa H, Asada H. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report. BMC Nephrol. 2019. https:\/\/doi.org\/10.1186\/s12882-019-1236-y.","journal-title":"BMC Nephrol"},{"key":"1006_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2017.10.014","author":"FJ Lin","year":"2018","unstructured":"Lin FJ, Zhang D, Chang J, Tang XL, Guan WB, Jiang GR, et al. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1. Eur J Med Genet. 2018. https:\/\/doi.org\/10.1016\/j.ejmg.2017.10.014.","journal-title":"Eur J Med Genet"},{"key":"1006_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329492","author":"C Takeuchi","year":"2024","unstructured":"Takeuchi C, Yamashita S, Liu YY, Takeshima H, Sasaki A, Fukuda M, et al. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 2024. https:\/\/doi.org\/10.1136\/gutjnl-2023-329492.","journal-title":"Gut"},{"key":"1006_CR22","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205158","author":"K Shen","year":"2023","unstructured":"Shen K, Chen B, Yang L, Gao W. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer. Aging. 2023. https:\/\/doi.org\/10.18632\/aging.205158.","journal-title":"Aging"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01006-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:32:17Z","timestamp":1758623537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01006-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1006"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01006-0","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this case report were in accordance with the ethical standards of the 1964 Helsinki declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}